Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCC. Amezalpat builds momentum with both Fast Track and Orphan Drug Designations.
A man in remission from a little known type of cancer has become one of the faces of a campaign to improve treatment alongside Dame Zandra Rhodes. Benjamin Carey, 55, wants to secure better treatment ...
Airdrie’s hockey community is coming together on Sunday, February 23, for a new way to honour Ryan Couling—retiring his #8 ...
Figure 1. Liquid biopsy for early detection of hepatocellular carcinoma: current state for clinical applications, strengths, and limitations. Images have been generated using AI-powered “text to image ...
HCC, hepatocellular carcinoma; CT, computed tomography ... Arterial phase (AP) and portal venous phase (VP) contrast-enhanced CT images with 1.25 mm reconstructed section thicknesses were selected to ...
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related ... Participants’ demographics, clinicopathological data, CT scan, histopathology images and diet habit were collected from ...
Hepatocellular carcinoma (HCC) is one of the deadliest cancers globally, with increasing incidence and mortality rates.
Unresectable canine hepatocellular carcinoma (HCC) has limited nonsurgical treatment options. Sorafenib is a targeted therapy for unresectable canine HCC. However, there are limited reports on the ...
Amezalpat is an investigational oral, small molecule, selective peroxisome proliferator-activated receptor-alpha antagonist.
Hepatocellular carcinoma (HCC) is one of the deadliest malignant tumors in the world, and its incidence and mortality have increased year by year. HCC research has increasingly focused on ...
Announcing a new publication for Acta Materia Medica journal. Icaritin (ICA) is a prenylflavonoid natural product extracted from plants of the Epimedium genus.